Parallel-Competitive Absorption-Presystemic Metabolism Model for Subcutaneous Bioavailability Prediction of Monoclonal Antibodies
Year: 2026
Type: article
Source: Molecular Pharmaceutics
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English
Subfield: Radiology, Nuclear Medicine and Imaging
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: Merck
OpenAlex ID: W7154462188
